Candel Therapeutics Inc (CADL)
7.05
+0.64
(+9.98%)
USD |
NASDAQ |
Apr 30, 16:00
7.14
+0.09
(+1.28%)
After-Hours: 07:00
Candel Therapeutics Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.124M |
| September 30, 2022 | 0.124M |
| June 30, 2022 | 0.124M |
| March 31, 2022 | 0.124M |
| December 31, 2021 | 0.124M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.124M |
| June 30, 2021 | 0.124M |
| March 31, 2021 | 0.124M |
| December 31, 2020 | 0.124M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.124M
Minimum
Dec 2020
0.124M
Maximum
Dec 2020
0.124M
Average
0.124M
Median
Dec 2020
Revenue (TTM) Benchmarks
| Allurion Technologies Inc | 53.47M |
| AngioDynamics Inc | 324.01M |
| Eliem Therapeutics Inc | -- |
| Macrogenics Inc | 56.91M |
| GlycoMimetics Inc | -- |